These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18517260)

  • 21. Terpenoids. III: Synthesis and biological evaluation of 23-hydroxybetulinic acid derivatives as novel inhibitors of glycogen phosphorylase.
    Zhu P; Bi Y; Xu J; Li Z; Liu J; Zhang L; Ye W; Wu X
    Bioorg Med Chem Lett; 2009 Dec; 19(24):6966-9. PubMed ID: 19889536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel thienopyrrole glycogen phosphorylase inhibitors: synthesis, in vitro SAR and crystallographic studies.
    Whittamore PR; Addie MS; Bennett SN; Birch AM; Butters M; Godfrey L; Kenny PW; Morley AD; Murray PM; Oikonomakos NG; Otterbein LR; Pannifer AD; Parker JS; Readman K; Siedlecki PS; Schofield P; Stocker A; Taylor MJ; Townsend LA; Whalley DP; Whitehouse J
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5567-71. PubMed ID: 16945526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystallographic studies on acyl ureas, a new class of glycogen phosphorylase inhibitors, as potential antidiabetic drugs.
    Oikonomakos NG; Kosmopoulou MN; Chrysina ED; Leonidas DD; Kostas ID; Wendt KU; Klabunde T; Defossa E
    Protein Sci; 2005 Jul; 14(7):1760-71. PubMed ID: 15987904
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovering benzamide derivatives as glycogen phosphorylase inhibitors and their binding site at the enzyme.
    Chen L; Li H; Liu J; Zhang L; Liu H; Jiang H
    Bioorg Med Chem; 2007 Nov; 15(21):6763-74. PubMed ID: 17719791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of novel oleanolic acid derivatives as potential antidiabetic agents.
    Zhang L; Jia X; Dong J; Chen D; Liu J; Zhang L; Wen X
    Chem Biol Drug Des; 2014 Mar; 83(3):297-305. PubMed ID: 24119242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of oleanolic acid dimers as inhibitors of glycogen phosphorylase.
    Cheng K; Liu J; Sun H; Xie J
    Chem Biodivers; 2010 Mar; 7(3):690-7. PubMed ID: 20232331
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of pentacyclic triterpenes derivatives as potent inhibitors against glycogen phosphorylase based on 3D-QSAR studies.
    Liang Z; Zhang L; Li L; Liu J; Li H; Zhang L; Chen L; Cheng K; Zheng M; Wen X; Zhang P; Hao J; Gong Y; Zhang X; Zhu X; Chen J; Liu H; Jiang H; Luo C; Sun H
    Eur J Med Chem; 2011 Jun; 46(6):2011-21. PubMed ID: 21439694
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Kinetic and crystallographic studies of glucopyranose spirohydantoin and glucopyranosylamine analogs inhibitors of glycogen phosphorylase.
    Watson KA; Chrysina ED; Tsitsanou KE; Zographos SE; Archontis G; Fleet GW; Oikonomakos NG
    Proteins; 2005 Dec; 61(4):966-83. PubMed ID: 16222658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural basis of the synergistic inhibition of glycogen phosphorylase a by caffeine and a potential antidiabetic drug.
    Tsitsanou KE; Skamnaki VT; Oikonomakos NG
    Arch Biochem Biophys; 2000 Dec; 384(2):245-54. PubMed ID: 11368311
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The binding of β-d-glucopyranosyl-thiosemicarbazone derivatives to glycogen phosphorylase: A new class of inhibitors.
    Alexacou KM; Tenchiu Deleanu AC; Chrysina ED; Charavgi MD; Kostas ID; Zographos SE; Oikonomakos NG; Leonidas DD
    Bioorg Med Chem; 2010 Nov; 18(22):7911-22. PubMed ID: 20947361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glycogen phosphorylase inhibitory effects of 2-oxo-1,2-dihydropyridin-3-yl amide derivatives.
    Karis ND; Loughlin WA; Jenkins ID; Healy PC
    Bioorg Med Chem; 2009 Jul; 17(13):4724-33. PubMed ID: 19443226
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of oxalyl derivatives of beta-d-glucopyranosylamine to muscle glycogen phosphorylase b.
    Hadjiloi T; Tiraidis C; Chrysina ED; Leonidas DD; Oikonomakos NG; Tsipos P; Gimisis T
    Bioorg Med Chem; 2006 Jun; 14(11):3872-82. PubMed ID: 16464598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CoMFA and docking studies on glycogen phosphorylase a inhibitors as antidiabetic agents.
    Prathipati P; Pandey G; Saxena AK
    J Chem Inf Model; 2005; 45(1):136-45. PubMed ID: 15667139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acyl ureas as human liver glycogen phosphorylase inhibitors for the treatment of type 2 diabetes.
    Klabunde T; Wendt KU; Kadereit D; Brachvogel V; Burger HJ; Herling AW; Oikonomakos NG; Kosmopoulou MN; Schmoll D; Sarubbi E; von Roedern E; Schönafinger K; Defossa E
    J Med Chem; 2005 Oct; 48(20):6178-93. PubMed ID: 16190745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Natural flavonoids as antidiabetic agents. The binding of gallic and ellagic acids to glycogen phosphorylase b.
    Kyriakis E; Stravodimos GA; Kantsadi AL; Chatzileontiadou DS; Skamnaki VT; Leonidas DD
    FEBS Lett; 2015 Jul; 589(15):1787-94. PubMed ID: 25980608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New pentacyclic triterpenes from Gypsophila oldhamiana and their biological evaluation as glycogen phosphorylase inhibitors.
    Luo JG; Liu J; Kong LY
    Chem Biodivers; 2008 May; 5(5):751-7. PubMed ID: 18493961
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Structure-activity relationships of flavonoids as potential inhibitors of glycogen phosphorylase.
    Kato A; Nasu N; Takebayashi K; Adachi I; Minami Y; Sanae F; Asano N; Watson AA; Nash RJ
    J Agric Food Chem; 2008 Jun; 56(12):4469-73. PubMed ID: 18494482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystallographic studies on N-azidoacetyl-beta-D-glucopyranosylamine, an inhibitor of glycogen phosphorylase: comparison with N-acetyl-beta-D-glucopyranosylamine.
    Petsalakis EI; Chrysina ED; Tiraidis C; Hadjiloi T; Leonidas DD; Oikonomakos NG; Aich U; Varghese B; Loganathan D
    Bioorg Med Chem; 2006 Aug; 14(15):5316-24. PubMed ID: 16616506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modeling aided design of potent glycogen phosphorylase inhibitors.
    Deng Q; Lu Z; Bohn J; Ellsworth KP; Myers RW; Geissler WM; Harris G; Willoughby CA; Chapman K; McKeever B; Mosley R
    J Mol Graph Model; 2005 Apr; 23(5):457-64. PubMed ID: 15781188
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core.
    Rath VL; Ammirati M; LeMotte PK; Fennell KF; Mansour MN; Danley DE; Hynes TR; Schulte GK; Wasilko DJ; Pandit J
    Mol Cell; 2000 Jul; 6(1):139-48. PubMed ID: 10949035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.